Kim Tan

Bio

Founder Chairman of SpringHill Management Ltd (UK), a specialist venture capital management company in biotech and pharmaceutical investments. SpringHill is also a pioneer in social venture capital investments, adopting an enterprise approach to tackling global poverty. Chairman of the NCI Cancer Hospital in Malaysia and a board director of a number of companies in Malaysia, India, the UK, South Africa and the US. Advisor to a number of government agencies in Asia on biotechnology and chairs the Access to Capital Working Group for the Asia Pacific Economic Community (APEC) Life Science Forum. Inventor of sheep monoclonal antibodies and a Fellow of the Royal Society of Medicine. Founding director of Transformational Business Network, the UK charity with social transformational businesses in developing countries, including the Kuzuko Game Reserve in South Africa. Was the former Chairman of Jubilee Action, the UK-based human rights organisation working with street children in India, Africa, Philippines and Brazil. PhD in biochemistry and was the recipient of a PhD scholarship and four post-doctoral fellowships from the Medical Research Council (UK).